This is a preview of subscription content, log in via an institution to check access.
Notes
Medical-writing and programming services for the study were funded by AstraZeneca.
Reference
Reibman J, et al. Clinical and Economic Burden of Severe Asthma Among US Patients Treated with Biologic Therapies. Annals of Allergy, Asthma and Immunology : 26 Mar 2021. Available from: URL: http://doi.org/10.1016/j.anai.2021.03.015
Rights and permissions
About this article
Cite this article
Severe asthma among US patients often uncontrolled despite biological therapies. PharmacoEcon Outcomes News 876, 30 (2021). https://doi.org/10.1007/s40274-021-7644-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7644-9